Skip to main content
logo
Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
2.945
-0.015 (-0.51%)
At close: Sep 25, 2026, 4:00 PM EDT
2.990
+0.045 (1.53%)
After-hours: Sep 25, 2026, 7:30 PM EDT

Sana Biotechnology Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
44.7144.364.0473.367.0650.41
Research & Development
140.34146.66207.43253.6204.37274.66
Operating Expenses
185.06190.96271.47326.9271.43325.07
Operating Income
-185.06-190.96-271.47-326.9-271.43-325.07
Interest & Investment Income
4.363.8510.479.943.760.68
Other Non Operating Income (Expenses)
4.874.61-0.01-0.05-0.670.31
EBT Excluding Unusual Items
-175.83-182.51-261.01-317.01-268.34-324.09
Asset Writedown
-2.3-46.91-6.39-7.01-4.5-
Other Unusual Items
-33.69-14.750.6440.773.36-31.84
Pretax Income
-211.82-244.17-266.76-283.26-269.48-355.93
Net Income
-211.82-244.17-266.76-283.26-269.48-355.93
Net Income to Common
-211.82-244.17-266.76-283.26-269.48-355.93
Net Income Growth
------
Shares Outstanding (Basic)
277253231195188166
Shares Outstanding (Diluted)
277253231195188166
Shares Change
17.07%9.68%18.68%3.29%13.16%1178.88%
EPS (Basic)
-0.76-0.96-1.16-1.46-1.43-2.14
EPS (Diluted)
-0.76-0.96-1.16-1.46-1.43-2.14
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-135.06-144.77-256.58-273.61-310.93-280.92
Free Cash Flow Per Share
-0.49-0.57-1.11-1.41-1.65-1.69
EBITDA
-174.19-178.21-255.97-309.36-255.8-314
D&A For EBITDA
10.8712.7515.517.5415.6311.07
EBIT
-185.06-190.96-271.47-326.9-271.43-325.07
SEC Filings: 10-K · 10-Q